Nb35 expression and purification

JB Julien Bous
HO Hélène Orcel
CL Cédric Leyrat
JL Joséphine Lai-Kee-Him
GG Gérald Gaibelet
AA Aurélie Ancelin
JS Julie Saint-Paul
ST Stefano Trapani
ML Maxime Louet
RS Rémy Sounier
HD Hélène Déméné
SG Sébastien Granier
ask Ask a question
Favorite

The production and purification of Nb35 were performed following a protocol established by Kobilka and co-workers (18). Nb35 having a C-terminal 6His-tag was expressed in the periplasm of Escherichia coli strain BL21 following induction with 1 mM isopropyl-β-d-thiogalactopyranoside. Cultures of 2L were grown to an optical density at 600 nm of 0.6 at 37°C in LB medium containing 0.1% glucose and ampicillin (100 μg/ml). Induced cultures were grown overnight at 25°C. Cells were harvested by centrifugation and lysed in ice-cold buffer [50 mM tris-HCl (pH 8), 125 mM sucrose, and 2 mM EDTA]. Lysate was centrifuged to remove cell debris, and Nb35 was purified by nickel affinity chromatography. Eluate was concentrated to 5 mg/ml and loaded onto a Superdex 200 (16/600 column, GE Healthcare) at a 1 ml/min of flowrate. Fractions containing the monodisperse peak of Nb35 were pooled and dialyzed overnight against a buffer containing 10 mM Hepes (pH 7.5) and 100 mM NaCl at room temperature (RT). The dialyzed sample was concentrated to approximately 100 mg/ml using a 10-kDa MWCO concentrator (Millipore). Aliquots were stored at −80°C until use.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A